$CRESY

Elsztain Fernando Adrian sold $10K of CRESY

Elsztain Fernando Adrian sold 10,000 shares of CRESUD INC (CRESY) at $1.05 on 2026-08-24.

Original reporting
SEC EDGAR · Elsztain Fernando Adrian
Published Aug 26, 2026, 4:39 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 26, 2026, 5:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CRESY
Neutral
high confidence
Mentioned
$CRESY
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CRESYNeutralLow
01

Why it matters

The sale is a routine liquidity event with no material impact on CRESY's valuation.

02

Market read

Limited relevance; typical insider sale with negligible trading implications.

03

What to watch

Potential upcoming corporate actions not disclosed.

Relevance 3/10Novelty 4/10Timing: post-market filing on 2026-08-26

Background

Form 4 filing reports insider transactions required by SEC regulations.

Company-level read

Ticker impact

$CRESYNeutralHigh confidence
Context

Director Elsztain Fernando Adrian sold 10,000 shares of CRESUD Inc at $1.05 per share, reducing his holdings to 615,736 shares.

Expected impact

Minimal downward pressure, likely negligible.

Evidence & confidence

The transaction size (~$10.5k) is trivial relative to market cap; typical for liquidity needs.

Market effects

None; isolated insider transaction.

No broader regional effect.

Not significant.

Counterpoint

Insider may anticipate short-term weakness, but size is too small to infer.

Key entities

  • CRESUD Inc

    Argentinian agribusiness listed on NYSE as CRESY.

  • Elsztain Fernando Adrian

    Director of CRESUD Inc who executed the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CRESYMed

CRESUD INC (CRESY): Financial results for FY2026

CRESUD INC (CRESY) furnished an SEC Form 6-K — earnings release. Yes o No x CRESUD S.A.C.I.F. and A. (THE “COMPANY”) REPORT ON FORM 6-K Attached is the English translation of the letter filed with the Comision Nacional de Valores and Bolsas y Mercados Argentinos S.A. on September 7, 2026. By letter dated September 7, 2026, the company reported

$ASPEMedAI 8/10

ARCH Venture Fund X, L.P. (CRANDELL KEITH, Burow Kristina) purchased $18.0M of ASPE (indirect holdings)

ARCH Venture Fund X, L.P. purchased 1,200,000 indirectly-held shares of Aspen Neuroscience, Inc. (ASPE) at $15.00 ($18.00M total) on 2026-11-02. Filed jointly with ARCH Venture Fund X Overage, L.P. (10% owner), ARCH Venture Partners X, L.P. (10% owner), ARCH Venture Partners X Overage, L.P. (10% owner), ARCH Venture Partners X, LLC (10% owner), CRANDELL KEITH (10% owner), Burow Kristina (10% owner), GILLIS STEVEN (10% owner) and NELSEN ROBERT (10% owner).

$ASPELow

ARCH Venture Fund X, L.P. (CRANDELL KEITH, Burow Kristina) purchased $2.0M of ASPE

ARCH Venture Fund X, L.P. purchased 133,333 shares of Aspen Neuroscience, Inc. (ASPE) at $15.00 ($2.00M total) across 2 trades on 2026-11-02. Filed jointly with ARCH Venture Fund X Overage, L.P. (10% owner), ARCH Venture Partners X, L.P. (10% owner), ARCH Venture Partners X Overage, L.P. (10% owner), ARCH Venture Partners X, LLC (10% owner), CRANDELL KEITH (10% owner), Burow Kristina (10% owner), GILLIS STEVEN (10% owner) and NELSEN ROBERT (10% owner).